This clinical evidence has indicated that (i) CRC tissues from patients show a more elevated SREBP-1 level than noncancerous tissues [22] and (ii) SREBP-1 mRNA level is higher in colon carcinomas [23]. The gene discussed is SREBF1; the disease is colon carcinoma.